mRNA and Antisense biotech - attracting the large fund managers and defining 2020
As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...
top of page
Search
Dec 9, 20203 min read
Ionis Pharmaceuticals - A force for life
RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...
509 views0 comments
Nov 29, 20206 min read
mRNA and RNA biotechnology – “The software of life”
The recent news that BioNTech and Pfizer’s Covid-19 vaccine was more than 90 per cent effective in clinical trials has increased...
1,572 views0 comments
Nov 27, 20203 min read
Australian biotech companies becoming global players
Australia has ranked in the top five globally for biotechnology three years running, outperforming nations such as the United Kingdom and...
93 views0 comments
Nov 26, 20202 min read
Antisense Therapeutics Limited dual-lists in Europe
An exciting and innovative Australian biotech - Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) has now listed on the Frankfurt...
120 views0 comments
bottom of page